Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MNKD

MannKind (MNKD)

MannKind Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MNKD
DatumZeitQuelleÜberschriftSymbolFirma
30/01/202503h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
06/01/202523h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
06/01/202522h30GlobeNewswire Inc.MannKind Expands Executive Leadership TeamNASDAQ:MNKDMannKind Corporation
18/12/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
18/12/202413h00GlobeNewswire Inc.MannKind Corporation Announces Exchange of Convertible Notes for Stock and CashNASDAQ:MNKDMannKind Corporation
16/12/202412h05GlobeNewswire Inc.MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
11/12/202412h00GlobeNewswire Inc.CDSCO Approves Afrezza® (insulin human) Inhalation Powder in IndiaNASDAQ:MNKDMannKind Corporation
26/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
22/11/202422h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
20/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
15/11/202422h01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
09/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
07/11/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNKDMannKind Corporation
07/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
07/11/202422h02GlobeNewswire Inc.MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:MNKDMannKind Corporation
06/11/202422h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
05/11/202422h15GlobeNewswire Inc.MannKind to Present at 2024 UBS Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
05/11/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
04/11/202412h05GlobeNewswire Inc.MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic DiseasesNASDAQ:MNKDMannKind Corporation
31/10/202421h05GlobeNewswire Inc.MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024NASDAQ:MNKDMannKind Corporation
30/09/202412h00GlobeNewswire Inc.More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
18/09/202412h15GlobeNewswire Inc.MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
10/09/202422h30GlobeNewswire Inc.MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
05/09/202403h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
03/09/202422h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
30/08/202422h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
30/08/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
30/08/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
30/08/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
30/08/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
 Showing the most relevant articles for your search:NASDAQ:MNKD